105 related articles for article (PubMed ID: 35930005)
1. Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively.
Bencivenga M; Simbolo M; Ciaparrone C; Vicentini C; Torroni L; Piredda ML; Sacco M; Alloggio M; Castelli C; Tomezzoli A; Scarpa A; De Manzoni G
Ann Surg; 2022 Nov; 276(5):822-829. PubMed ID: 35930005
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Zhang D; Zhou S; Liu B
Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
[TBL] [Abstract][Full Text] [Related]
3. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways.
Yang M; Arai E; Takahashi Y; Totsuka H; Chiku S; Taniguchi H; Katai H; Sakamoto H; Yoshida T; Kanai Y
Carcinogenesis; 2020 Nov; 41(11):1473-1484. PubMed ID: 32710740
[TBL] [Abstract][Full Text] [Related]
4. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
[TBL] [Abstract][Full Text] [Related]
5. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
[TBL] [Abstract][Full Text] [Related]
6. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
7. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue.
Heo YJ; Park C; Yu D; Lee J; Kim KM
Sci Rep; 2019 Jul; 9(1):9675. PubMed ID: 31273278
[TBL] [Abstract][Full Text] [Related]
8. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
9. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
10. Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition.
Tanabe S; Aoyagi K; Yokozaki H; Sasaki H
Int J Oncol; 2014 Jun; 44(6):1955-70. PubMed ID: 24728500
[TBL] [Abstract][Full Text] [Related]
11. FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma.
Wang Y; Shi T; Wang X; Hu J; Yu L; Liu Q; Wu N; Liu B; Wei J
J Transl Med; 2021 Sep; 19(1):401. PubMed ID: 34551773
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
[TBL] [Abstract][Full Text] [Related]
13. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity.
Yao F; Kausalya JP; Sia YY; Teo AS; Lee WH; Ong AG; Zhang Z; Tan JH; Li G; Bertrand D; Liu X; Poh HM; Guan P; Zhu F; Pathiraja TN; Ariyaratne PN; Rao J; Woo XY; Cai S; Mulawadi FH; Poh WT; Veeravalli L; Chan CS; Lim SS; Leong ST; Neo SC; Choi PS; Chew EG; Nagarajan N; Jacques PÉ; So JB; Ruan X; Yeoh KG; Tan P; Sung WK; Hunziker W; Ruan Y; Hillmer AM
Cell Rep; 2015 Jul; 12(2):272-85. PubMed ID: 26146084
[TBL] [Abstract][Full Text] [Related]
15. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
16. COL8A1 Predicts the Clinical Prognosis of Gastric Cancer and Is Related to Epithelial-Mesenchymal Transition.
She Y; Zhao X; Wu P; Xue L; Wan S; Zhang L; Li C; Cai H; Li Y
Biomed Res Int; 2022; 2022():7567447. PubMed ID: 35774273
[TBL] [Abstract][Full Text] [Related]
17. Bridging genomics and phenomics of gastric carcinoma.
Cho J; Ahn S; Son DS; Kim NK; Lee KW; Kim S; Lee J; Park SH; Park JO; Kang WK; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim KM
Int J Cancer; 2019 Nov; 145(9):2407-2417. PubMed ID: 30801717
[TBL] [Abstract][Full Text] [Related]
18. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
[TBL] [Abstract][Full Text] [Related]
19. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
20. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Wilson MR; Reske JJ; Holladay J; Wilber GE; Rhodes M; Koeman J; Adams M; Johnson B; Su RW; Joshi NR; Patterson AL; Shen H; Leach RE; Teixeira JM; Fazleabas AT; Chandler RL
Nat Commun; 2019 Aug; 10(1):3554. PubMed ID: 31391455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
